-
International Urogynecology Journal Apr 2023This systematic review (PROSPERO:CRD42022275789) is aimed at comparing qualitatively the success, recurrence, and complication rates of sacrocolpopexy with concomitant... (Review)
Review
INTRODUCTION AND HYPOTHESIS
This systematic review (PROSPERO:CRD42022275789) is aimed at comparing qualitatively the success, recurrence, and complication rates of sacrocolpopexy with concomitant hysterectomy, hysteropexy, sacrospinous fixation (SSF) with and without vaginal hysterectomy (VH) and uterosacral fixation (USF) with and without VH.
METHODS
A systematic search was performed using Embase, PubMed, Scopus, and Cochrane databases for studies published from 2011, on women with apical pelvic organ prolapse requiring surgical interventions. Risk of bias was assessed via the National Institutes of Health study quality assessment tool. The primary outcomes are the success and recurrence rate of each technique, for ≥12 months' follow-up. Findings were summarised qualitatively.
RESULTS
A total of 21 studies were included. Overall significant findings for a high success and low recurrence rate are summarised as: minimally invasive sacrocolpopexy (MISC) is superior to abdominal sacrocolpopexy (ASC); sacrospinous hysteropexy (SSHP) is superior to USF + VH, which is superior to uterosacral hysteropexy and mesh hysteropexy (MHP). Significant findings related to complications include: MISC recorded a lower overall complication rate than ASC except in mesh exposure; USF + VH tends to perform better than SSHP and SSF, with SSHP performing better than MHP in faecal incontinence and overactive bladder rates.
CONCLUSION
There is no evidence to conclude that hysterectomy is superior to uterine-sparing approaches. MISC should be considered over ASC given similar efficacy and reduced complications. Superiority of MHP is unproven against native tissue hysteropexy. Further studies under standardised settings are required for direct comparisons between the surgical management methods.
Topics: Female; Humans; Gynecologic Surgical Procedures; Treatment Outcome; Pelvic Organ Prolapse; Uterus; Hysterectomy
PubMed: 36462058
DOI: 10.1007/s00192-022-05408-x -
Diagnostic accuracy of interleukin-2 receptor in sarcoidosis: a systematic review and meta-analysis.Expert Review of Respiratory Medicine 2023Soluble interleukin-2 receptor (sIL-2 R), a valuable diagnostic biomarker for sarcoidosis, has been reported with variable results. Based on the literatures currently... (Meta-Analysis)
Meta-Analysis Review
INTRODUCTION
Soluble interleukin-2 receptor (sIL-2 R), a valuable diagnostic biomarker for sarcoidosis, has been reported with variable results. Based on the literatures currently accessible, a systematic review and meta-analysis of the diagnostic performance of serum sIL-2 R for sarcoidosis were performed.
METHODS
Relevant studies investigating sIL-2 R for sarcoidosis diagnosis in several databases were searched and data on sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) were pooled by STATA 16.0 software. Overall test performance was assessed using summary receiver operating characteristic curves and the area under the curve (AUC). Potential publication bias was assessed by Deeks test.
RESULTS
We included eleven studies involving 1,424 subjects, with 1,099 cases of sarcoidosis and 325 of non-sarcoidosis. The pooled parameters of sIL-2 R in diagnosing sarcoidosis were summarized as follows: sensitivity, 0.85 (95% CI: 0.72-0.93); specificity, 0.88 (95% CI: 0.72-0.96); PLR, 7.3 (95% CI: 2.7-20.1); NLR, 0.17 (95% CI:0.08-0.36); DOR, 44 (95% CI: 8-231); and the AUC, 0.93 (95% CI: 0.90-0.95). No publication bias was identified ( = 0.64).
CONCLUSIONS
Evidence suggests sIL-2 R performs well in diagnosing sarcoidosis. Nevertheless, results of sIL-2 R assay should be interpreted with other diagnostic examinations.
Topics: Humans; Sensitivity and Specificity; ROC Curve; Receptors, Interleukin-2; Sarcoidosis
PubMed: 37334768
DOI: 10.1080/17476348.2023.2225772 -
Sports Medicine - Open Dec 2019The sport of strongman is becoming increasingly popular, catering for females, lightweight, and Masters competitors, with strongman exercises also being used by strength... (Review)
Review
BACKGROUND
The sport of strongman is becoming increasingly popular, catering for females, lightweight, and Masters competitors, with strongman exercises also being used by strength and conditioning coaches for a range of athletic groups. Thus, a systematic review was conducted to examine researchers' current understanding of the biomechanics of strongman exercises, with a view to improve strongman athlete performance, provide biomechanical evidence supporting the transferability of strongman exercises to strength and conditioning/rehabilitation programs, and identify gaps in the current knowledge of the biomechanics of strongman exercises.
METHODS
A two-level search term strategy was used to search five databases for studies relevant to strongman exercises and biomechanics.
RESULTS
Eleven articles adherent to the inclusion criteria were returned from the search. The studies provided preliminary biomechanical analysis of various strongman exercises including the key biomechanical performance determinants of the farmer's walk, heavy sled pull, and tire flip. Higher performing athletes in the farmer's walk and heavy sled pull were characterized by a greater stride length and stride rate and reduced ground contact time, while higher performing athletes in the tire flip were characterized by a reduced second pull phase time when compared with lower performing athletes. Qualitative comparison of carrying/walking, pulling and static lifting strongman, traditional weight training exercises (TWTE), and common everyday activities (CEA), like loaded carriage and resisted sprinting, were discussed to further researchers' understanding of the determinants of various strongman exercises and their applications to strength and conditioning practice. A lack of basic quantitative biomechanical data of the yoke walk, unilateral load carriage, vehicle pull, atlas stone lift and tire flip, and biomechanical performance determinants of the log lift were identified.
CONCLUSIONS
This review has demonstrated the likely applicability and benefit of current and future strongman exercise biomechanics research to strongman athletes and coaches, strength and conditioning coaches considering using strongman exercises in a training program, and tactical operators (e.g., military, army) and other manual labor occupations. Future research may provide a greater understanding of the biomechanical determinants of performance, potential training adaptations, and risks expected when performing and/or incorporating strongman exercises into strength and conditioning or injury rehabilitation programs.
PubMed: 31820223
DOI: 10.1186/s40798-019-0222-z -
Archivos Espanoles de Urologia Dec 2021Nowadays, Robotic assistedkidney transplantation (RAKT) is considered a lessinvasive alternative to the Open Kidney Transplantation(OKT) with several advantages such as...
OBJECTIVES
Nowadays, Robotic assistedkidney transplantation (RAKT) is considered a lessinvasive alternative to the Open Kidney Transplantation(OKT) with several advantages such as image magnification,3D vision and articulated instruments and with arelatively short learning curve for an experienced surgeon.RAKT has shown comparable outcomes with theOKT literature data in terms of surgical and functionalresults. RAKT may decrease the complication rate, meanhospital stay, postoperative pain, and also improve aestheticoutcomes. The aim of this study was to perform asystematic review of the literature on this novel approachof KT.
MATERIALS AND METHODS
A systematic review was performed in accordance with the Preferred ReportingItems for Systematic Reviews and Meta-Analyses (PRISMA)statement. The search was conducted using the databases PubMed/Medline, including as outcomes: (1) indications, (2) step-by-step technique for RAKT, (3) RAKT in special cases (4) surgical and functional outcomes,and (5) future perspectives in RAKT.
RESULTS
The indications for RAKT are expanding, sothat including obese recipients, graft with multiple vesselsand graft from deceased donor. To date, the two absolute contraindications to RAKT are patients unfitfor pneumoperitoneum and presenting advanced atheromatic plaques where vessel clamping could result challenging. As far as the outcomes, the surgical and functional results are in line with the OKT experience.Complication rate is low in RAKT, particularly in terms of arterial and venous thrombosis (1%), lymphocele (3%),ureteral stricture (2%), and wound infection (0.3%). Arobotic assisted kidney auto-transplantation (RAKAT) has been recently described, as novel approach in case of complex proximal benign ureteral stenosis. Despite great advances in this field, some limits still need to be approached such as the modality to main tain the graft to a constant low temperature ( <20 ºC) and to find the proper location of arteriotomy in advanced atheromatic disease without the tactile feedback.
CONCLUSION
The present review has confirmed that RAKT is as safe and feasible as OKT with comparable surgical and functional results. Complication rate is lower in RAKT than OKT and the indications are expanding quickly. Furthermore, new technologies are being introduced in order to improve the surgical performances and to expand more the indications for robotic surgery.However, a prospective randomized study in order to compare RAKT versus OKT is still required.
Topics: Humans; Kidney Transplantation; Operative Time; Prospective Studies; Robotic Surgical Procedures; Robotics; Treatment Outcome
PubMed: 34851312
DOI: No ID Found -
Journal of the International Society of... 2016Carbohydrate supplements are widely used by athletes as an ergogenic aid before and during sports events. The present systematic review and meta-analysis aimed at... (Meta-Analysis)
Meta-Analysis Review
BACKGROUND
Carbohydrate supplements are widely used by athletes as an ergogenic aid before and during sports events. The present systematic review and meta-analysis aimed at synthesizing all available data from randomized controlled trials performed under real-life conditions.
METHODS
MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched systematically up to February 2015. Study groups were categorized according to test mode and type of performance measurement. Subgroup analyses were done with reference to exercise duration and range of carbohydrate concentration. Random effects and fixed effect meta-analyses were performed using the Software package by the Cochrane Collaboration Review Manager 5.3.
RESULTS
Twenty-four randomized controlled trials met the objectives and were included in the present systematic review, 16 of which provided data for meta-analyses. Carbohydrate supplementations were associated with a significantly shorter exercise time in groups performing submaximal exercise followed by a time trial [mean difference -0.9 min (95 % confidence interval -1.7, -0.2), p = 0.02] as compared to controls. Subgroup analysis showed that improvements were specific for studies administering a concentration of carbohydrates between 6 and 8 % [mean difference -1.0 min (95 % confidence interval -1.9, -0.0), p = 0.04]. Concerning groups with submaximal exercise followed by a time trial measuring power accomplished within a fixed time or distance, mean power output was significantly higher following carbohydrate load (mean difference 20.2 W (95 % confidence interval 9.0, 31.5), p = 0.0004]. Likewise, mean power output was significantly increased following carbohydrate intervention in groups with time trial measuring power within a fixed time or distance (mean difference 8.1 W (95 % confidence interval 0.5, 15.7) p = 0.04].
CONCLUSION
Due to the limitations of this systematic review, results can only be applied to a subset of athletes (trained male cyclists). For those, we could observe a potential ergogenic benefit of carbohydrate supplementation especially in a concentration range between 6 and 8 % when exercising longer than 90 min.
Topics: Athletes; Athletic Performance; Bicycling; Dietary Carbohydrates; Dietary Supplements; Exercise; Humans; Randomized Controlled Trials as Topic; Sports Nutritional Physiological Phenomena
PubMed: 27408608
DOI: 10.1186/s12970-016-0139-6 -
Cognitive Processing Feb 2021Psychometric, historiometric and psychiatric studies are controversial on a hypothetical link between psychopathology and creativity. In this study, we will try to... (Meta-Analysis)
Meta-Analysis Review
Psychometric, historiometric and psychiatric studies are controversial on a hypothetical link between psychopathology and creativity. In this study, we will try to contribute to this debate by analysing the case of autism. Is there a relationship between autism and creativity? If so, can we find the same relationship in a watered-down form in subjects with autistic traits? In order to answer these questions, we carried out a systematic literature review of the studies on this topic published in the last 10 years. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We also conducted a meta-analysis of data. We found that in the clinical population there are fewer creative performances than in control groups; nonetheless, it is possible to delineate a medium creative profile of subjects with autism. The average creative profile of people with autism shows that they are inhibited in fluency and flexibility, but that they display a high level of detail and a particularly high level of originality in works either generated during tests or created in private time. In particular, the level of detail reached in the latter condition seems to be higher in the autistic population than in the control groups. Better linguistic skills appear to be linked to better creative performances. Linguistic tests, if compared with visual and performative tests, seem to favour the expression of originality in subjects with autism. Although our data on autistic traits are compatible with the hypothesis that a high level of autistic traits is a watered-down replica of the cognitive profile of subjects with autism, we have no sufficient data to support this hypothesis.
Topics: Autistic Disorder; Creativity; Humans; Psychometrics
PubMed: 33057954
DOI: 10.1007/s10339-020-00992-6 -
Sports (Basel, Switzerland) May 2020The purpose of this article was to review the data on the relationship between multi-joint isometric strength test (IsoTest) force-time characteristics (peak force, rate... (Review)
Review
The purpose of this article was to review the data on the relationship between multi-joint isometric strength test (IsoTest) force-time characteristics (peak force, rate of force development and impulse) and dynamic performance that is available in the current literature. Four electronic databases were searched using search terms related to IsoTest. Studies were considered eligible if they were original research studies that investigated the relationships between multi-joint IsoTest and performance of dynamic movements; published in peer-reviewed journals; had participants who were athletes or active individuals who participate in recreational sports or resistance training, with no restriction on sex; and had full text available. A total of 47 studies were selected. These studies showed significant small to large correlations between isometric bench press (IBP) force-time variables and upper body dynamic performances ( = 0.221 to 0.608, < 0.05) and significant small to very large correlation between isometric squat (ISqT) ( = 0.085 to 0.746, < 0.05) and isometric mid-thigh pull (IMTP) ( = 0.120 to 0.941, < 0.05) force-time variables with lower body dynamic performances. IsoTest force-time characteristics were shown to have small to very large correlations with dynamic performances of the upper and lower limbs as well as performance of sporting movements ( = 0.118 to 0.700, < 0.05). These data suggest that IsoTest force-time characteristics provide insights into the force production capability of athletes which give insight into dynamic performance capabilities.
PubMed: 32429176
DOI: 10.3390/sports8050063 -
The Lancet. Digital Health Dec 2023Machine learning and deep learning models have been increasingly used to predict long-term disease progression in patients with chronic obstructive pulmonary disease... (Meta-Analysis)
Meta-Analysis
Machine learning and deep learning predictive models for long-term prognosis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
BACKGROUND
Machine learning and deep learning models have been increasingly used to predict long-term disease progression in patients with chronic obstructive pulmonary disease (COPD). We aimed to summarise the performance of such prognostic models for COPD, compare their relative performances, and identify key research gaps.
METHODS
We conducted a systematic review and meta-analysis to compare the performance of machine learning and deep learning prognostic models and identify pathways for future research. We searched PubMed, Embase, the Cochrane Library, ProQuest, Scopus, and Web of Science from database inception to April 6, 2023, for studies in English using machine learning or deep learning to predict patient outcomes at least 6 months after initial clinical presentation in those with COPD. We included studies comprising human adults aged 18-90 years and allowed for any input modalities. We reported area under the receiver operator characteristic curve (AUC) with 95% CI for predictions of mortality, exacerbation, and decline in forced expiratory volume in 1 s (FEV). We reported the degree of interstudy heterogeneity using Cochran's Q test (significant heterogeneity was defined as p≤0·10 or I>50%). Reporting quality was assessed using the TRIPOD checklist and a risk-of-bias assessment was done using the PROBAST checklist. This study was registered with PROSPERO (CRD42022323052).
FINDINGS
We identified 3620 studies in the initial search. 18 studies were eligible, and, of these, 12 used conventional machine learning and six used deep learning models. Seven models analysed exacerbation risk, with only six reporting AUC and 95% CI on internal validation datasets (pooled AUC 0·77 [95% CI 0·69-0·85]) and there was significant heterogeneity (I 97%, p<0·0001). 11 models analysed mortality risk, with only six reporting AUC and 95% CI on internal validation datasets (pooled AUC 0·77 [95% CI 0·74-0·80]) with significant degrees of heterogeneity (I 60%, p=0·027). Two studies assessed decline in lung function and were unable to be pooled. Machine learning and deep learning models did not show significant improvement over pre-existing disease severity scores in predicting exacerbations (p=0·24). Three studies directly compared machine learning models against pre-existing severity scores for predicting mortality and pooled performance did not differ (p=0·57). Of the five studies that performed external validation, performance was worse than or equal to regression models. Incorrect handling of missing data, not reporting model uncertainty, and use of datasets that were too small relative to the number of predictive features included provided the largest risks of bias.
INTERPRETATION
There is limited evidence that conventional machine learning and deep learning prognostic models demonstrate superior performance to pre-existing disease severity scores. More rigorous adherence to reporting guidelines would reduce the risk of bias in future studies and aid study reproducibility.
FUNDING
None.
Topics: Adult; Humans; Reproducibility of Results; Deep Learning; Quality of Life; Pulmonary Disease, Chronic Obstructive; Prognosis
PubMed: 38000872
DOI: 10.1016/S2589-7500(23)00177-2 -
The American Surgeon Dec 2023Completion pancreatectomy (C.P.) is one acceptable treatment of choice in clinical scenarios such as management of post-pancreatectomy complications and recurrence in... (Review)
Review
BACKGROUND/OBJECTIVE (S)
Completion pancreatectomy (C.P.) is one acceptable treatment of choice in clinical scenarios such as management of post-pancreatectomy complications and recurrence in the pancreatic remnant. Studies referring to completion pancreatectomy as a distinct operation are limited, without emphasizing at the operation itself, rather reporting completion pancreatectomy as a possible option for treatment of various diseases. The identification of indications of CP in various pathologies and the clinical outcomes are therefore mandatory.
METHODS
A systematic literature search was performed in the Pubmed and Scopus Databases (February 2020),guided by the PRISMA protocol, for all studies reporting CP as a surgical procedure with reference at indications for performing it combined with postoperative morbidity and/or mortality.
RESULTS
Out of 1647 studies, 32 studies from 10 countries with 2775 patients in total, of whom 561 (20.2%) CPs met the inclusion criteria and were included in the analysis. Inclusion year ranged from 1964 to 2018 and were published from 1992 until 2019. 17 studies with a total number of 249 CPs were performed for post-pancreatectomy complications. Mortality rate was 44.5% (111 out of 249). Morbidity rate was (72.6%). 12 studies with 225 CPs were performed for isolated local recurrence after initial resection with a morbidity rate of 21.5% and 0% mortality rate in the early postoperative period. Two studies with a total number of 12 patients reported CP as a treatment option for recurrent neuroendocrine neoplasms. The mortality in those studies was 8% (1/12) and the mean morbidity rate was 58.3% (7/12). Finally, CP for refractory chronic pancreatitis was presented in one study with morbidity and mortality rates of 19% and 0%, respectively.
CONCLUSION
Completion pancreatectomy is a distinct treatment option for various pathologies. Morbidity and mortality rates depend on the indications of performing CP, the status performance of the patients and whether the operation is performed electively or urgently
Topics: Humans; Pancreatectomy; Pancreatic Neoplasms; Neoplasm Recurrence, Local; Pancreas; Pancreatitis, Chronic; Retrospective Studies; Postoperative Complications
PubMed: 37295804
DOI: 10.1177/00031348231183121 -
Journal of Stroke and Cerebrovascular... Nov 2023Stroke diagnosis is dependent on lengthy clinical and neuroimaging assessments, while rapid treatment initiation improves clinical outcome. Currently, more sensitive... (Meta-Analysis)
Meta-Analysis
BACKGROUND
Stroke diagnosis is dependent on lengthy clinical and neuroimaging assessments, while rapid treatment initiation improves clinical outcome. Currently, more sensitive biomarker assays of both non-coding RNA- and protein biomarkers have improved their detectability, which could accelerate stroke diagnosis. This systematic review and meta-analysis compares non-coding RNA- with protein biomarkers for their potential to diagnose and differentiate acute stroke (subtypes) in (pre-)hospital settings.
METHODS
We performed a systematic review and meta-analysis of studies evaluating diagnostic performance of non-coding RNA- and protein biomarkers to differentiate acute ischemic and hemorrhagic stroke, stroke mimics, and (healthy) controls. Quality appraisal of individual studies was assessed using the QUADAS-2 tool while the meta-analysis was performed with the sROC approach and by assessing pooled sensitivity and specificity, diagnostic odds ratios, positive- and negative likelihood ratios, and the Youden Index.
SUMMARY OF REVIEW
112 studies were included in the systematic review and 42 studies in the meta-analysis containing 11627 patients with ischemic strokes, 2110 patients with hemorrhagic strokes, 1393 patients with a stroke mimic, and 5548 healthy controls. Proteins (IL-6 and S100 calcium-binding protein B (S100B)) and microRNAs (miR-30a) have similar performance in ischemic stroke diagnosis. To differentiate between ischemic- or hemorrhagic strokes, glial fibrillary acidic protein (GFAP) levels and autoantibodies to the NR2 peptide (NR2aAb, a cleavage product of NMDA neuroreceptors) were best performing whereas no investigated protein or non-coding RNA biomarkers differentiated stroke from stroke mimics with high diagnostic potential.
CONCLUSIONS
Despite sampling time differences, circulating microRNAs (< 24 h) and proteins (< 4,5 h) perform equally well in ischemic stroke diagnosis. GFAP differentiates stroke subtypes, while a biomarker panel of GFAP and UCH-L1 improved the sensitivity and specificity of UCH-L1 alone to differentiate stroke.
Topics: Humans; Hemorrhagic Stroke; Stroke; Biomarkers; Ischemic Stroke; Glial Fibrillary Acidic Protein; MicroRNAs; RNA, Untranslated
PubMed: 37778160
DOI: 10.1016/j.jstrokecerebrovasdis.2023.107388